Previous
Article | Table of Contents
| Next
Article
Biochemistry
Structure of the
GCN5 histone acetyltransferase bound to a bisubstrate inhibitor
, .gif)
, ¶
||
**
,
**
The Wistar
Institute, and
Department of Chemistry, University of Pennsylvania,
Philadelphia, PA 19104;
Department of Pharmacology and Molecular Sciences, The Johns Hopkins University,
Baltimore, MD 21205; and¶ Faculty of Chemistry, University of
Wroclaw, 50-383, Wroclaw, Poland
Edited by Gregory A. Petsko, Brandeis University, Waltham, MA, and approved September 5, 2002 (received for review June 21, 2002)
Histone acetyltransferases (HATs) use acetyl CoA to acetylate target lysine residues within histones and other transcription factors, such as the p53 tumor suppressor, to promote gene activation. HAT enzymes fall into subfamilies with divergence in sequence and substrate preference. Several HAT proteins have been implicated in human cancer. We have previously reported on the preparation of peptide-CoA conjugate inhibitors with distinct specificities for the p300/CBP [cAMP response element binding protein (CREB)-binding protein] or GCN5 HAT subfamilies. Here we report on the crystal structure of the GCN5 HAT bound to a peptide-CoA conjugate containing CoA covalently attached through an isopropionyl linker to Lys-14 of a 20-aa N-terminal fragment of histone H3. Surprisingly, the structure reveals that the H3 portion of the inhibitor is bound outside of the binding site for the histone substrate and that only five of the 20 aa residues of the inhibitor are ordered. Rearrangements within the C-terminal region of the GCN5 protein appear to mediate this peptide displacement. Mutational and enzymatic data support the hypothesis that the observed structure corresponds to a late catalytic intermediate. The structure also provides a structural scaffold for the design of HAT-specific inhibitors that may have therapeutic applications for the treatment of HAT-mediated cancers.
Abbreviations: HAT, histone acetyltransferase; HDAC, histone deacetylase; tGCN5, Tetrahymena GCN5; PCAF, p300/CBP-associating factor; hPCAF, human PCAF; AcCoA, acetyl CoA; CBP, cAMP response element binding protein (CREB) binding protein
** To whom correspondence may be addressed. E-mail: pcole{at}jhmi.edu or marmor{at}wistar.upenn.edu .
This paper was submitted directly (Track II) to the PNAS office.
Data deposition: The atomic coordinates have been deposited in the Protein Data Bank, http://www.rcsb.org/ (PDB ID code 1M1D).
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
What's this?
This article has been cited by other articles in HighWire Press-hosted journals: (Search Google Scholar for Other Citing Articles)
![]() |
C. A. Toleman, A. J. Paterson, and J. E. Kudlow The Histone Acetyltransferase NCOAT Contains a Zinc Finger-like Motif Involved in Substrate Recognition J. Biol. Chem., February 17, 2006; 281(7): 3918 - 3925. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
J. Cleary, K. V. Sitwala, M. S. Khodadoust, R. P. S. Kwok, N. Mor-Vaknin, M. Cebrat, P. A. Cole, and D. M. Markovitz p300/CBP-associated Factor Drives DEK into Interchromatin Granule Clusters J. Biol. Chem., September 9, 2005; 280(36): 31760 - 31767. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
F. Guidez, L. Howell, M. Isalan, M. Cebrat, R. M. Alani, S. Ivins, I. Hormaeche, M. J. McConnell, S. Pierce, P. A. Cole, J. Licht, and A. Zelent Histone Acetyltransferase Activity of p300 Is Required for Transcriptional Repression by the Promyelocytic Leukemia Zinc Finger Protein Mol. Cell. Biol., July 1, 2005; 25(13): 5552 - 5566. [Abstract] [Full Text] [PDF] |
||||
|
| |||||
![]() |
C. Toleman, A. J. Paterson, T. R. Whisenhunt, and J. E. Kudlow Characterization of the Histone Acetyltransferase (HAT) Domain of a Bifunctional Protein with Activable O-GlcNAcase and HAT Activities J. Biol. Chem., December 17, 2004; 279(51): 53665 - 53673. [Abstract] [Full Text] [PDF] |
||||
|
| |||||